Professor Inge Marie Svane is breaking new ground with Immunotherapy

Ugeskr Læger 178/17 22. august 2016

20 years ago, as a medical intern, Inge Marie Svane never would have guessed that she would be apart of the scientific breakthroughs which are today improving survival rates for cancer patients. Immunotherapy has been proclaimed to be the key to treat patients with a various cancer forms. Professor Svane is currently principal investigator for several clinical trials applying cellular-based immunotherapy to patients with metastatic melanoma, renal cell and ovarian cancers - offering the most promising hope for patients with advanced stage disease.